Affordable Access

Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease.

Authors
  • Harskamp, Ralf E
  • Zheng, Zhe
  • Alexander, John H
  • Williams, Judson B
  • Xian, Ying
  • Halkos, Michael E
  • Brennan, J Matthew
  • de Winter, Robbert J
  • Smith, Peter K
  • Lopes, Renato D
Type
Published Article
Journal
The Annals of Thoracic Surgery
Publisher
Elsevier
Publication Date
Dec 01, 2013
Volume
96
Issue
6
Pages
2268–2277
Identifiers
PMID: 24446561
Source
Medline
License
Unknown

Abstract

Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials.

Report this publication

Statistics

Seen <100 times